Walleye Trading’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Sell
8,300
-4,000
-33% -$52.9K ﹤0.01% 3340
2026
Q1
$169K Buy
12,300
+2,500
+26% +$37.7K ﹤0.01% 3215
2025
Q4
$177K Buy
9,800
+7,100
+263% +$127K ﹤0.01% 3461
2025
Q3
$50K Buy
+2,700
New +$42.4K ﹤0.01% 3961
2025
Q1
– Sell
-23,600
Closed -$520K – 4134
2024
Q4
$520K Sell
23,600
-3,100
-12% -$59.7K ﹤0.01% 2609
2024
Q3
$450K Buy
+26,700
New +$396K ﹤0.01% 2578

Other funds holding CLBT

Walleye Trading's CLBT Position: Q2 2026 in Review

Walleye Trading sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 5,328 shares — an estimated $70.4K sold.

Walleye Trading first reported a position in CLBT in Q3 2024 and held it in 3 quarters. The position peaked at $112K in Q3 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Walleye Trading reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 5,328 Cellebrite shares in Q2 2026, an estimated $70.4K.
  • Walleye Trading first reported a position in Cellebrite in Q3 2024 and held it in 3 quarters.
  • Walleye Trading's Cellebrite position peaked at $112K in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.